Hepatitis A vaccine removed from routine US childhood recommendations, experts warn
This is an editorial summary of research originally reported by The Lancet. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
The US government removed hepatitis A vaccine from routine childhood immunizations in January 2026, moving it only to high-risk groups. Without universal vaccination, hepatitis A outbreaks could spread more easily among children and vulnerable populations. Experts warn that this change risks reversing decades of progress in preventing this serious liver infection.
# Editorial Summary
In early 2026, U.S. health authorities reportedly changed guidance by removing several vaccines, including hepatitis A protection, from the list of routine vaccines recommended for all children. Under the new guidance, hepatitis A vaccination is now primarily recommended only for children considered at higher risk rather than as a universal childhood vaccine. This change marks a departure from decades of public health strategy aimed at preventing hepatitis A outbreaks across the general population.
Hepatitis A is a viral infection that affects the liver and spreads through contaminated food and water or close contact with infected individuals. While most people recover fully from hepatitis A, the infection can cause severe illness, particularly in older adults and people with existing liver disease. Before hepatitis A vaccine became a routine childhood immunization, the virus caused thousands of cases annually in the United States. The vaccine has been credited with dramatically reducing hepatitis A cases over the past two decades.
The rationale behind removing hepatitis A from universal vaccination recommendations reflects a shift in risk assessment by federal health agencies including the CDC, FDA, and NIH. However, public health experts have expressed concern that moving away from universal childhood vaccination could allow hepatitis A to resurface in communities, particularly among unvaccinated children and vulnerable populations who may not qualify as "high risk" under the new guidelines.
For parents and caregivers, it's important to discuss hepatitis A vaccination with your child's doctor, even if it's no longer automatically recommended. Ask whether your child should receive the vaccine based on your family's circumstances, travel plans, or community health status. If you have questions about whether hepatitis A protection is right for your child, your healthcare provider can help you make an informed decision based on current risk factors in your area.
What you can doAI-generated
- ✓Check whether your child falls into a higher-risk category for hepatitis A exposure—such as living in areas with documented hepatitis A outbreaks, having close contact with someone infected with hepatitis A, or having a family member with chronic liver disease—and discuss hepatitis A vaccination with your pediatrician if they do.
- ✓Ask your child's healthcare provider whether the hepatitis A vaccine should still be given to your child despite the removal from routine recommendations, since protection against this liver infection through vaccination is no longer automatically offered to all children under the new 2026 guidance.
- ✓Review your own hepatitis A vaccination status, as adults who were not vaccinated during childhood may want to discuss vaccination with their doctor, particularly if you work in food service, childcare, or other settings with higher exposure risk to the hepatitis A virus.
- ✓Learn the symptoms of hepatitis A infection—including yellowing of the skin or eyes, abdominal pain, and dark urine—so you can seek medical care quickly if you or your child develops these signs, since the virus spreads through contaminated food and water.
Always consult a healthcare professional for personal medical advice.
Read the full report at the original source
The LancetWas this finding useful?
Community discussion
Join the discussion
Comments are reviewed before appearing publicly.